Milestones in the pathogenesis and management of primary liver cancer
Liver cancer is a major global health problem whose incidence is on the rise. The improvement in the understanding of the pathogenesis, early detection, diagnosis, staging and treatment of liver cancer has been enormous. The landscape of molecular aberrations driving both hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA) have been unravelled. Several breakthroughs have occurred in the prevention, surveillance and treatment of HCC. Particularly, management of patients at advanced stages has changed dramatically during the last decade with the advent of effective systemic therapies such as sorafenib, lenvatinib, regorafenib, cabozantinib and ramucirumab.
Source: Journal of Hepatology - Category: Gastroenterology Authors: Jean-Charles Nault, Ann-Lii Cheng, Bruno Sangro, Josep M. Llovet Tags: Editorial Source Type: research
More News: Bile Duct Cancer | Cancer | Cancer & Oncology | Carcinoma | Cholangiocarcinoma | Gastroenterology | Hepatocellular Carcinoma | Liver | Liver Cancer | Urology & Nephrology